Advertisement
Canada markets closed
  • S&P/TSX

    21,554.86
    -26.49 (-0.12%)
     
  • S&P 500

    5,464.62
    -8.55 (-0.16%)
     
  • DOW

    39,150.33
    +15.57 (+0.04%)
     
  • CAD/USD

    0.7302
    -0.0004 (-0.05%)
     
  • CRUDE OIL

    82.34
    +0.17 (+0.21%)
     
  • Bitcoin CAD

    88,337.75
    +531.76 (+0.61%)
     
  • CMC Crypto 200

    1,352.88
    -7.44 (-0.55%)
     
  • GOLD FUTURES

    2,334.70
    -34.30 (-1.45%)
     
  • RUSSELL 2000

    2,022.03
    +4.64 (+0.23%)
     
  • 10-Yr Bond

    4.2570
    +0.0030 (+0.07%)
     
  • NASDAQ

    17,689.36
    -32.23 (-0.18%)
     
  • VOLATILITY

    13.20
    -0.08 (-0.60%)
     
  • FTSE

    8,237.72
    -34.74 (-0.42%)
     
  • NIKKEI 225

    38,596.47
    -36.55 (-0.09%)
     
  • CAD/EUR

    0.6826
    +0.0005 (+0.07%)
     

Well Health Stock Is Up 7% After Earnings: What Investors Need to Know

healthcare pharma
Image source: Getty Images

Written by Karen Thomas, MSc, CFA at The Motley Fool Canada

Technology companies like Well Health Technologies (TSX:WELL) are changing the world for the better. As a result, demand is high and expectations are high. Well Health Technologies reported its first-quarter earnings, which were a reflection of this — Well Health Technologies’s stock price is therefore up 7% since.

Here’s what you need to know.

Well Health’s momentum remains strong

The first quarter was the 21st consecutive quarter of record-breaking results. Revenue increased 36.7% to $231 million, with organic growth of 13.5%, as patient visits soared 34% versus last year. This was accompanied by a 6.1% increase in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to $28.3 million. Finally, adjusted earnings per share (EPS) came in at $0.08 cents versus $0.06 cents last year and versus consensus expectations that were calling for EPS of negative $0.04.

ADVERTISEMENT

Beyond this obvious strong momentum, the company signalled that it is now ready and able to focus more on shareholder returns. It’s what every investor wants to hear, and it comes right on time. This means making good use of its growing free cash flow. In the quarter, free cash flow increased 11%, and for the year, management expects free cash flow to increase 30% to $50 million.

Also, management has made a commitment to reduce share-based compensation as well as increase share buybacks, effectively reducing or eliminating dilution in Well Health stock.

The primary care market in Canada is a big opportunity for Well Health

In terms of future growth and opportunities, the primary care market in Canada is a big one for Well Health. This is because the market is a very large one, which is very fragmented, with Well Health having a mere 1% market share — and Well Health is facing little competition as of now.

In the first quarter, revenue from the primary care business increased 83% to $45.3 million. In 2024, management expects revenue of more than $300 million, which they expect to exceed $1 billion in the not-too-distant future. This assumes that Well Health has a 10% market share at that point.

So, as you can see, the opportunity is significant — and Well Health is getting there rapidly.

Artificial intelligence to power healthcare

Another really interesting aspect of Well Health’s story is the opportunity to use artificial intelligence (AI) to improve healthcare — from efficiencies to disease detection and management to patient care. Examples of this include AI Voice, for transcribing, effectively eliminating human error in the transcribing process as well as cost. There is also AI Inbox Administration, which is an automation software that automatically files faxes to charts.

These AI-enabled processes sound simple, but daily use of these will have the effect of reducing costs, increasing efficiencies, and lessening the workload so healthcare professionals can focus more on patient care.

But the most exciting potential of AI, is its ability to directly improve patient outcomes. For example, AI Decision Support acts as a co-pilot for the physician. It provides risk stratification, harnessing clinical data and AI to screen for and find patients at-risk for over 100 different chronic and rare diseases. This has the potential to improve patient outcomes by leaps and bounds.

The bottom line

As you can see from this article, I feel very optimistic about Well Health Technologies from many different angles. From the value of its business to the company’s improving financials, I think that Well Health is really in a sweet spot right now.

This will drive Well Health Technologies’s stock price significantly higher over the next few years, in my view.

The post Well Health Stock Is Up 7% After Earnings: What Investors Need to Know appeared first on The Motley Fool Canada.

Should you invest $1,000 in WELL Health Technologies right now?

Before you buy stock in WELL Health Technologies, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the 10 best stocks for investors to buy now… and WELL Health Technologies wasn’t one of them. The 10 stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $15,578.55!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 32 percentage points since 2013*.

See the 10 stocks * Returns as of 3/20/24

More reading

Fool contributor Karen Thomas has a position in Well Health Technologies. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

2024